Neville Rodie & Shaw’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.5M Buy
15,988
+897
+6% +$699K 0.92% 30
2025
Q1
$12.5M Buy
15,091
+60
+0.4% +$49.6K 0.98% 30
2024
Q4
$11.6M Buy
15,031
+97
+0.6% +$74.9K 0.85% 34
2024
Q3
$13.2M Sell
14,934
-439
-3% -$389K 0.97% 30
2024
Q2
$13.9M Buy
15,373
+207
+1% +$187K 1.06% 25
2024
Q1
$11.8M Buy
15,166
+716
+5% +$557K 0.9% 32
2023
Q4
$8.42M Buy
14,450
+1,420
+11% +$828K 0.69% 39
2023
Q3
$7M Buy
13,030
+460
+4% +$247K 0.62% 40
2023
Q2
$5.9M Buy
12,570
+9,940
+378% +$4.66M 0.51% 49
2023
Q1
$903K Buy
2,630
+690
+36% +$237K 0.08% 137
2022
Q4
$710K Buy
1,940
+665
+52% +$243K 0.07% 148
2022
Q3
$412K Buy
1,275
+75
+6% +$24.2K 0.04% 184
2022
Q2
$389K Hold
1,200
0.03% 196
2022
Q1
$351K Hold
1,200
0.03% 216
2021
Q4
$331K Hold
1,200
0.02% 217
2021
Q3
$277K Hold
1,200
0.02% 224
2021
Q2
$275K Hold
1,200
0.02% 227
2021
Q1
$224K Hold
1,200
0.02% 240
2020
Q4
$203K Buy
+1,200
New +$203K 0.02% 242
2019
Q3
Sell
-2,200
Closed -$244K 242
2019
Q2
$244K Sell
2,200
-33
-1% -$3.66K 0.03% 219
2019
Q1
$290K Buy
2,233
+33
+2% +$4.29K 0.03% 207
2018
Q4
$255K Hold
2,200
0.03% 201
2018
Q3
$236K Buy
+2,200
New +$236K 0.02% 229
2015
Q3
Sell
-2,600
Closed -$217K 261
2015
Q2
$217K Buy
+2,600
New +$217K 0.02% 250
2013
Q4
Sell
-66,610
Closed -$3.35M 261
2013
Q3
$3.35M Sell
66,610
-8,750
-12% -$440K 0.39% 69
2013
Q2
$3.7M Buy
+75,360
New +$3.7M 0.45% 62